Literature DB >> 33710011

Current treatment strategies for symptomatic vitreous opacities.

Edwin H Ryan1.   

Abstract

PURPOSE OF REVIEW: Symptomatic vitreous opacities are increasingly recognized as a significant burden to patient well-being. There is growing interest in the use of vitrectomy or laser treatment to address these problems. This review is intended to update current assessment, management, and risks of treatment for persistent severely symptomatic vitreous opacities. RECENT
FINDINGS: Despite studies showing the value of quantitative ultrasound, reading speed measurements, and contrast sensitivity for assessing dysfunction caused by vitreous opacities, the decision of whether to proceed with surgery remains a very subjective, clinical one. Visual Function Questionnaire-25 score studies show a very large improvement postvitrectomy consistent with relief from symptoms and patient satisfaction. The risk of retinal tear and detachment appears to be higher than in most conditions treated with vitrectomy.
SUMMARY: Vitrectomy for the management of severe vitreous opacities is increasingly accepted because of the tremendous relief of symptoms reported by patients. The risks of retinal tear and detachment remain a concern, particularly in patients who have an attached posterior hyaloid. Yttrium-aluminum-garnet laser treatment of floaters may offer benefit in a subset of patients but appears to be less definitive than vitrectomy, and also may carry significant risk.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33710011     DOI: 10.1097/ICU.0000000000000752

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  2 in total

1.  Vitreous Opacity Vitrectomy (VOV): Safest Possible Removal of "Floaters".

Authors:  Robert E Morris
Journal:  Clin Ophthalmol       Date:  2022-06-01

2.  Evaluation of Foldable Capsular Vitreous Body Implantation Surgery.

Authors:  Liying Luo; Qingquan Wei; Qing Liu; Li Wang; Yanyun Jiang
Journal:  Int J Gen Med       Date:  2022-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.